Stereotaxis (STXS) EBT Margin Growth (3y) (2013 - 2026)
Stereotaxis (STXS) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -19.00 |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 803.00 |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -1,015.00 |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 918.00 |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -388.00 |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -1,195.00 |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -1,725.00 |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 4.00 |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn | -11,361.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,361.00 |
| Dec 31, 2025 | -1,626.00 |
| Sep 30, 2025 | -2,283.00 |
| Jun 30, 2025 | 2,114.00 |
| Mar 31, 2025 | -1,901.00 |
| Dec 31, 2024 | -9,028.00 |
| Sep 30, 2024 | -1,452.00 |
| Jun 30, 2024 | -9,594.00 |
| Mar 31, 2024 | -4,769.00 |
| Dec 31, 2023 | -9,545.00 |
| Sep 30, 2023 | -5,032.00 |
| Jun 30, 2023 | -2,330.00 |
| Mar 31, 2023 | -4,280.00 |
| Dec 31, 2022 | -3,813.00 |
| Sep 30, 2022 | -6,104.00 |
| Jun 30, 2022 | -5,728.00 |
| Mar 31, 2022 | -2,498.00 |
| Dec 31, 2021 | -3,800.00 |
| Sep 30, 2021 | -5,412.00 |
| Jun 30, 2021 | -3,322.00 |